These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21406269)

  • 1. Myeloid cell population dynamics in healthy and tumor-bearing mice.
    Ueha S; Shand FH; Matsushima K
    Int Immunopharmacol; 2011 Jul; 11(7):783-8. PubMed ID: 21406269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells.
    Younos I; Donkor M; Hoke T; Dafferner A; Samson H; Westphal S; Talmadge J
    Int Immunopharmacol; 2011 Jul; 11(7):816-26. PubMed ID: 21376153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional changes in myeloid-derived suppressor cells (MDSCs) during tumor growth: FKBP51 contributes to the regulation of the immunosuppressive function of MDSCs.
    Kim YS; Kim YJ; Lee JM; Kim EK; Park YJ; Choe SK; Ko HJ; Kang CY
    J Immunol; 2012 May; 188(9):4226-34. PubMed ID: 22474024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful colon cancer eradication after chemoimmunotherapy is associated with profound phenotypic change of intratumoral myeloid cells.
    Medina-Echeverz J; Fioravanti J; Zabala M; Ardaiz N; Prieto J; Berraondo P
    J Immunol; 2011 Jan; 186(2):807-15. PubMed ID: 21148040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early exposure of high-dose interleukin-4 to tumor stroma reverses myeloid cell-mediated T-cell suppression.
    Jiang J; Wang Z; Li Z; Zhang J; Wang C; Xu X; Qin Z
    Gene Ther; 2010 Aug; 17(8):991-9. PubMed ID: 20410929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice.
    Haile LA; Gamrekelashvili J; Manns MP; Korangy F; Greten TF
    J Immunol; 2010 Jul; 185(1):203-10. PubMed ID: 20525890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.
    Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE
    Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression.
    Zhang M; Liu Q; Mi S; Liang X; Zhang Z; Su X; Liu J; Chen Y; Wang M; Zhang Y; Guo F; Zhang Z; Yang R
    J Immunol; 2011 Apr; 186(8):4716-24. PubMed ID: 21383238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy.
    Talmadge JE
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5243-8. PubMed ID: 17875751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
    Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
    J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of regulatory T cells facilitates growth of established tumors: a mechanism involving the regulation of myeloid-derived suppressor cells by lipoxin A4.
    Zhang B; Jia H; Liu J; Yang Z; Jiang T; Tang K; Li D; Huang C; Ma J; Shen GX; Ye D; Huang B
    J Immunol; 2010 Dec; 185(12):7199-206. PubMed ID: 21068404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.
    Marigo I; Dolcetti L; Serafini P; Zanovello P; Bronte V
    Immunol Rev; 2008 Apr; 222():162-79. PubMed ID: 18364001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cell-deficient Kit(W-sh) "Sash" mutant mice display aberrant myelopoiesis leading to the accumulation of splenocytes that act as myeloid-derived suppressor cells.
    Michel A; Schüler A; Friedrich P; Döner F; Bopp T; Radsak M; Hoffmann M; Relle M; Distler U; Kuharev J; Tenzer S; Feyerabend TB; Rodewald HR; Schild H; Schmitt E; Becker M; Stassen M
    J Immunol; 2013 Jun; 190(11):5534-44. PubMed ID: 23636054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen specificity of immune suppression by myeloid-derived suppressor cells.
    Solito S; Bronte V; Mandruzzato S
    J Leukoc Biol; 2011 Jul; 90(1):31-6. PubMed ID: 21486906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine.
    Ko HJ; Lee JM; Kim YJ; Kim YS; Lee KA; Kang CY
    J Immunol; 2009 Feb; 182(4):1818-28. PubMed ID: 19201833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid-derived suppressor cells in parasitic infections.
    Van Ginderachter JA; Beschin A; De Baetselier P; Raes G
    Eur J Immunol; 2010 Nov; 40(11):2976-85. PubMed ID: 21061431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer.
    D'Amico L; Mahajan S; Capietto AH; Yang Z; Zamani A; Ricci B; Bumpass DB; Meyer M; Su X; Wang-Gillam A; Weilbaecher K; Stewart SA; DeNardo DG; Faccio R
    J Exp Med; 2016 May; 213(5):827-40. PubMed ID: 27045006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-derived suppressor cell heterogeneity in human cancers.
    Solito S; Marigo I; Pinton L; Damuzzo V; Mandruzzato S; Bronte V
    Ann N Y Acad Sci; 2014 Jun; 1319():47-65. PubMed ID: 24965257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-derived osteopontin suppresses antitumor immunity by promoting extramedullary myelopoiesis.
    Kim EK; Jeon I; Seo H; Park YJ; Song B; Lee KA; Jang Y; Chung Y; Kang CY
    Cancer Res; 2014 Nov; 74(22):6705-16. PubMed ID: 25273090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tumor-induced myeloid-derived suppressor cell function by a nanoparticulated adjuvant.
    Fernández A; Mesa C; Marigo I; Dolcetti L; Clavell M; Oliver L; Fernández LE; Bronte V
    J Immunol; 2011 Jan; 186(1):264-74. PubMed ID: 21135171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.